Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
I made a profit with INO but about 1/2 of what I could have by getting too greedy. I was in INO way before Covid. I learned a lot from management the last year and not much is encouraging, the reason why I only hold a small amount today. My major sector today is Energy.